Navigation Links
Researchers investigate links between prostate, cadmium, zinc
Date:1/30/2008

Cadmium exposure is a known risk factor for prostate cancer, and a new University of Rochester study suggests that zinc may offer protection against cadmium.

In an article published in the February 2008 journal, The Prostate, epidemiologist Edwin van Wijngaarden, Ph.D., reports that PSA levels were 22 percent higher among American men who had zinc levels below the median (less than 12.67 mg/daily) and cadmium levels above the median. (PSA is a protein produced by the cells of the prostate gland. The higher a mans PSA level, the more likely cancer is present.)

In contrast, among men with a greater than median zinc intake, little evidence of an association between cadmium and PSA was found.

The way zinc and cadmium interact within human organs is significant and provides interesting leads for study, van Wijngaarden said. Zinc stimulates production of a protein that binds cadmium thereby taking it out of circulation and reducing its toxic effects.

However, it is too early to recommend zinc supplements for those whore worried about prostate damage, he added.

Your health is based on the complex interplay of many factors, said Van Wijngaarden, an assistant professor in the Department of Community and Preventive Medicine at the University of Rochester Medical Center. Environmental exposures play out differently in people. Its important to identify those subpopulations that may be more sensitive to toxicities.

The study was based on data from a sample of 1,320 men registered in the National Health and Nutrition Examination Survey (NHANES) 2001-2002, which was the first time PSA levels were available. In men over age 40, urinary cadmium levels were measured in about one-third of the sample and dietary zinc intake was reported based on 24-hour recall. Information on all three variables was available for a total of 422 men.

Cadmium exposure occurs mostly through smoking and diet, the latter as a result of fertilizer-soaked soil used for growing crops. Cadmium is also a byproduct of the industrial process used for making fungicides, batteries, pigments and coatings that protect metals from corrosion. Workers in those areas are at risk for much higher exposures. When ingested or inhaled, cadmium collects in the liver, kidneys and prostate.

Prostate cancer is the most frequently diagnosed non-skin malignancy in the United States. Nearly 219,000 new cases and 27,000 deaths were expected in 2007.

Zinc is an important nutrient to maintain health. However, the jury is still out on the benefits of large quantities zinc and van Wijngaarden cautioned that some studies show it may do more harm than good when taken as a dietary supplement. Zinc toxicity can harm the immune system, reduce beneficial cholesterol, and alter iron function.

This type of inconsistency may be explained by variability in certain populations, he said. Epidemiologists often focus on single exposures, but biology is not that simple. The latest research suggests we should be studying the interplay of exposures on certain subgroups of people and how they vary.


'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. New nanotube findings by Stanford researchers give boost to potential biomedical applications
2. Researchers Map Paths Governing Neuron Function
3. Cold Spring Harbor Laboratory researchers race against time to save Tasmanian devils
4. Researchers at Peoria Pulmonary Associates to study airway bypass procedure for emphysema
5. Pain medicine meeting unites top researchers and clinicians
6. Researchers identify brains eureka circuitry
7. Researchers find relief for chronic pain
8. Researchers propose consumers buy yearly drug licenses as new way to pay for prescriptions
9. Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
10. DOE awards supercomputing time to UCSD, SDSC researchers
11. Argonnes Blue Gene/P to host large cadre of INCITE researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: